Results 151 to 160 of about 617,337 (267)
Reconfigurable second-harmonic generation via plasmonic nanoslits counteracting strain-induced suppression in monolayer MoS<sub>2</sub>. [PDF]
Sharma S +10 more
europepmc +1 more source
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach +9 more
wiley +1 more source
Chiral Nonlinear Enhancement with Opposite Circular Dichroism Empowered by Dual Bound States in the Continuum. [PDF]
Liu X, Wang L, Meng H.
europepmc +1 more source
Enhanced Material Estimation with Multi-Spectral CT
Sandamali Devadithya, David Castañón
openaire +1 more source
Single‐cell DNA methylation (scDNAme) profiling maps epimutational clonal evolution, revealing mechanisms of malignancy and therapeutic resistance across diverse cancer types. By providing a high‐resolution landscape of intratumoral heterogeneity, these technologies empower precise patient stratification, guide the development of enhanced ...
Ik Soo Kim
wiley +1 more source
Plasmonic and surface-enhanced Raman nanobiosensors for quantitative molecular detection. [PDF]
Kim Y +9 more
europepmc +1 more source
Enhancement of Material Functions by Laser Materials Processing.
openaire +2 more sources
Interferon type 1 (IFN‐1) production and signaling is associated with the acquisition of therapy resistance, following chronic DNA damage, via Interferon‐related DNA damage resistance signature (IRDS) gene expression. An alternative, DNA damage‐independent role of sustained IFN‐1 mediated resistance was identified and characterized by the emergence of ...
Ashlyn Conant +11 more
wiley +1 more source
Nonuniform Chemical Passivation Dynamics in Monolayer MoS<sub>2</sub> from Real-Time Photoluminescence Imaging. [PDF]
Lim J +7 more
europepmc +1 more source
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source

